Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
October 05, 2023 07:05 ET | uniQure Inc.
~ Reduction of 28% of workforce not related to HEMGENIX® manufacturing obligations; Total cost savings of $180 million to extend cash runway into second quarter of 2027 ~ ~ Discontinuing investments...
Superlatus, Inc. Announces New Appointments to the Management Team
June 27, 2023 08:00 ET | Superlatus, Inc.
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”) (“the Company), a U.S.-based holding company of food products and distribution capabilities, which on June 23, 2023...
Annette Edel
Porsche Cars Canada appoints new Chief Financial Officer
February 02, 2023 09:01 ET | Porsche Cars Canada, Ltd.
Toronto, ON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Porsche Cars Canada, Ltd. (PCL) is pleased to announce Annette Edel as its Chief Financial Officer, effective March 1, 2023. Edel will take the reins...
NMD_Logo3_reg.jpg
NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer
May 10, 2022 07:00 ET | NMD Pharma
PRESS RELEASE NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Dr. Quiroz brings extensive US and European clinical and regulatory expertiseRole will be based in Boston,...
Blender Bites Marks Milestone Achievements While Transitioning to Major Production Stage
Blender Bites Marks Milestone Achievements While Transitioning to Major Production Stage
May 07, 2022 19:10 ET | Blender Bites Limited
VANCOUVER, British Columbia, May 07, 2022 (GLOBE NEWSWIRE) -- Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL40, WKN: A3DWAM), an award-winning Canadian company...
Immunicum AB: Immuni
Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer
May 05, 2022 02:00 ET | Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, announced the appointment of Leopold...
Immunicum AB: Immuni
Immunicum AB: Immunicum utser Leopold Bertea till Chief Technology Officer
May 05, 2022 02:00 ET | Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, tillkännagav utnämningen av Leopold Bertea, PhD,...
new logo.jpg
Blink Charging to Participate at the Capital One Securities 16th Annual Energy Conference
November 30, 2021 09:15 ET | Blink Charging Co.
Miami Beach, FL, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging...
Immunicum Appoints L
Immunicum Appoints Lotta Ferm as Chief Financial Officer
October 26, 2021 02:00 ET | Immunicum AB
Press Release 26 October 2021 Immunicum Appoints Lotta Ferm as Chief Financial Officer Immunicum AB (publ; IMMU.ST) today announced the appointment of Lotta Ferm as Chief Financial Officer...
Immunicum utser Lott
Immunicum utser Lotta Ferm till CFO
October 26, 2021 02:00 ET | Immunicum AB
Pressmeddelande 26 oktober 2021 Immunicum utser Lotta Ferm till CFO Immunicum AB (publ; IMMU.ST) tillkännagav idag att Lotta Ferm utsetts till Chief Financial Officer (CFO) från och med den 1...